Interwell Health Appoints Dr. Carney Taylor as CMO to Boost Value-Based Kidney Care
- Interwell Health, a subsidiary of Fresenius Medical Care, appointed Dr. Carney Taylor as chief medical officer to enhance kidney care.
- Dr. Taylor aims to strengthen clinical strategy and physician engagement within Interwell's network of 2,300 nephrologists.
- The appointment reflects Fresenius Medical Care's commitment to advancing innovative, value-based kidney care for improved patient outcomes.
Interwell Health Appoints Dr. Carney Taylor to Enhance Value-Based Kidney Care
Interwell Health, a prominent entity in the value-based kidney care sector and a subsidiary of Fresenius Medical Care AG & Co. KGaA, announces the appointment of Dr. Carney Taylor, MD, MBA, as its new chief medical officer. This strategic move follows the retirement of Dr. George Hart, the former CMO, who will continue to support the organization in a strategic advisory capacity. Dr. Taylor, with over 25 years of experience in nephrology, aims to leverage his extensive background to strengthen the clinical strategy, physician engagement, and quality initiatives at Interwell Health.
Dr. Taylor’s previous roles include serving as the associate chief medical officer and board member at Interwell, highlighting his deep-rooted connection with the organization. His leadership is expected to foster a collaborative approach among the company’s network of 2,300 nephrologists, which is critical for shaping Interwell’s clinical direction. He has a proven track record of collaborating with healthcare practices, notably through co-leading Eastern Nephrology Associates in North Carolina, one of the initial practices to partner with Interwell and a significant contributor to the federal value-based kidney care program.
Under Dr. Taylor’s guidance, Interwell Health is poised to expand its innovative value-based kidney care model, focusing on empowering clinicians to enhance patient outcomes and effectively manage costs for payers. He emphasizes that the success of this model hinges on sustainable, physician-led strategies that cater to complex, high-risk populations. By implementing data-driven methodologies and specialized electronic health records, Interwell Health is committed to not only achieving excellence in patient care but also improving the overall satisfaction of nephrologists in their practice.
In addition to Dr. Taylor's appointment, Interwell Health reinforces its commitment to enhancing the quality of kidney care through collaboration and innovation. The company recognizes the growing importance of value-based care as payers increasingly prioritize sustainable strategies for managing kidney disease.
As the landscape of kidney care evolves, the leadership transition at Interwell Health marks a significant step toward advancing its mission to provide high-quality, patient-centered care while ensuring that nephrologists can thrive in their practice and deliver optimal outcomes for their patients.